Basic Information
Spear Bio's immunoassay technology, developed by Harvard University scientists, enables ultra-sensitive detection from small sample volumes and is compatible with existing sample collection, processing, and testing workflows. Ultra-sensitive immunoassays, capable of biomarker discovery, early detection, and home collection, are driving goals for researchers and clinicians advancing the field of proteomics.
Spear Bio Inc.
Massachusetts,United States of America
15~50 people
January 01, 2021
info@spear.bio

